Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Jie Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2752-2098; OpenAlex author ID A5100333008. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper

Papers 4

  1. Landmarks in pancreatic cancer studies. Co-author DOI 10.1186/s12935-022-02803-8↗
  2. The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response. Co-author DOI 10.1002/humu.24133↗
  3. Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.695645↗
  4. Meta‑analysis of current chemotherapy regimens in advanced pancreatic cancer to prolong survival and reduce treatment‑associated toxicities. Co-author DOI 10.3892/mmr.2018.9638↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fan Xu · 3 shared papers, 2019–2022 · strength 0.41
  2. Xiechuan Weng · 2 shared papers, 2021–2022 · strength 0.31
  3. Liqiong Yang · 1 shared paper, 2021 · strength 0.15
  4. Qing Li · 1 shared paper, 2021 · strength 0.15
  5. Sara H. Olson · 1 shared paper, 2021 · strength 0.12
  6. Yue Zhang · 1 shared paper, 2021 · strength 0.12
  7. Paul R. Andreassen · 1 shared paper, 2021 · strength 0.12
  8. Robert C. Kurtz · 1 shared paper, 2021 · strength 0.12
  9. Shu Yang · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.